|
Ascorbic Acid - Concentration/Dosage 100 Mg/Ml, Pharmaceutical Form Injectable Solution, Presentation Form In Ampoule With 5 Ml, Intravenous Route Of Administration, Amino Acids - 10 (100Mg/Ml), Polyamino Acid, Solution, Bottle With 100Ml, Infusion, Atropine, Sulfate - Concentration/Dosage 0, 25 Mg/Ml, Pharmaceutical Form Injectable Solution, Ampoule Presentation Form With 1Ml, Intravenous Administration Route, Sodium Bicarbonate - Pharmaceutical Form Injectable Solution, Concentration/Dosage 8, 4, Ampoule Presentation Form 10Ml, Bisacodyl - Concentration/Dosage 5 Mg, Pharmaceutical Form Tablet Or Dragee, Oral Administration Route, Bromopride - Concentration/Dosage 5 Mg/Ml, Ampoule Presentation Form With 2Ml, Intravenous Or Intramuscular Administration Route, Potassium Chloride - A 10, Pharmaceutical Form Injectable Solution, Ampoule Presentation Form With 10Ml, The Packaging Must Bring External Data Identification, Batch Number, Manufacturing Date And Expiry Date. At The Delivery Date, The Product Must Have At Least 75% Of Its Total Shelf Life. According To Ordinance 2814 Gm/1998, The Product Must Present In Its Primary And/Or Secondary Packaging, Potassium Chloride - In An Injectable Solution At 19.1, In An Ampoule With 10 Ml, The Packaging Must Have External Identification Data, Date Of Manufacture And Expiration Date. Its Primary And/Or Secondary Packaging, Potassium Chloride - Concentration/Dosage 60 Mg/Ml, Pharmaceutical Form Oral Solution, Bottle Presentation Form, Sodium Chloride - Sodium Chloride In Injectable Solution 20 In Ampoule With 10 Ml, Packed As Appeared In The Product Registration. The Packaging Must Bear Identification Data, Date Of Manufacture And Expiration Date On The Outside. On The Delivery Date, At A Minimum, The Product Must Present In Its Primary And/Or Secondary Packaging, The Expression, Glucose Sodium Chloride - Salts For Oral Rehydration (Sodium Chloride 3.5G Anhydrous Glucose Potassium Chloride 1.5G Sodium Citrate 2.9G), Powder For Oral Solution, Envelope 27.9G, Dimenhydrinate Pyridoxine Glucose Fructose - Concentration/Dosage 3 Mg/Ml 5 Mg/Ml 100 Mg/Ml 100 Mg/Ml Respectively, Ampoule Presentation Form, Dimenhydrinate Pyridoxine - Concentration/Dosage 25 Mg/Ml 5 Mg/Ml Respectively, Pharmaceutical Solution Form, Presentation Form Bottle With 20Ml, Oral Administration. The Packaging Must Bear Externally The Identification Data, Domperidone - Concentration/Dosage 1 Mg/Ml, Oral Suspension Presentation, Presentation Form Bottle With 100 Ml, The Packaging Must Carry Externally The Identification Data, The Product Must Have A Minimum Shelf Life., Scopolamine, Butylbromide - Concentration/Dosage 10 Mg/Ml, Butylbromide - Concentration/Dosage 10 Mg, Pharmaceutical Tablet Or Dragee Form, Butylbromide - Concentration/Dosage 20 Mg/Ml, Parenteral Route Of Administration, Sodium Dipyrone Butylbromide - Concentration/Dosage 4Mg/Ml And 500 Mg/Ml Respectively, Ampoule Presentation Form With 5Ml, Dipyrone Sodium Butylbromide - Concentration/Dosage 6.67 Mg/Ml 333.4 Mg/Ml Respectively, Presentation Bottle With 20Ml, Manufacturing Date And Expiry Date. On Delivery Date, Glibenclamide - Concentration/Dosage 5 Mg, Tablet Pharmaceutical Form, Oral Administration Route, Glycerol - Adult, In Suppository, Packed In Strip, Anal, Glycerol - Childrens Glycerol, Suppository, As Per Product Registration., Glyco
|
